Affiliate disclosure: Care Path Compare may receive compensation if you use the Trimi link and make a purchase, at no extra cost to you. We did not have a compensated Nouri relationship when this comparison was published. Compensation does not determine our comparison or conclusions.
Nouri vs Trimi at a glance
| Factor | Nouri | Trimi |
|---|---|---|
| Program model | Telehealth program combining compounded medication, nutrition planning, movement planning, and clinician messaging | Telehealth program combining compounded medication, clinician access, supplies, support, and shipping |
| Medications advertised | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Lowest semaglutide price shown | $120/month on the semi-annual cadence | $99/month equivalent on a $1,188 annual prepaid plan |
| True monthly semaglutide price | Confirm at checkout | $175/month |
| Lowest tirzepatide price shown | Starts at $175/month | $125/month equivalent on a $1,500 annual prepaid plan |
| True monthly tirzepatide price | Confirm at checkout | $235/month |
| Dose-related price changes | Nouri says any prescribed dose is the same price | Trimi says plan price stays the same across prescribed doses |
| Clinical partner named | Wasef Health, PC | Arora Health |
| Pharmacy information | Nouri names F&F Pharmacies Inc. dba Jungle Jim’s Pharmacy on its current FAQ | Trimi names VialsRx and GreenwichRx on current program materials |
| State availability claimed | All 50 states; some states may require a video visit | All 50 states; confirm availability for the proposed prescription |
| Compounded drugs FDA-approved? | No | No |
Prices and terms were checked September 13, 2026 and can change. Published prices do not establish eligibility or guarantee that a prescription will be issued.
The biggest difference is the program structure
Nouri presents its weight-care service as a bundled program rather than only a medication-and-clinician pathway. Its current site says the price includes compounded medication when prescribed, a personalized nutrition plan, a movement plan, physician messaging, and free expedited shipping.
Trimi’s current treatment pages emphasize an all-in-one medication program that includes compounded medication when prescribed, injection supplies, provider access, ongoing support, and shipping. Its biggest pricing distinction is the choice among monthly, three-month, six-month, and annual billing.
Neither model is automatically better. A consumer who values structured nutrition and movement planning may care more about Nouri’s bundled support. A consumer focused mainly on transparent plan-length choices may care more about Trimi’s published billing ladder.
Nouri pricing in 2026
Nouri’s current public FAQ says:
- Compounded semaglutide starts at $120 per month on the semi-annual cadence.
- Compounded tirzepatide starts at $175 per month.
- Nutrition planning, movement planning, physician messaging, and free expedited shipping are included.
- Nouri says the price is the same across prescribed doses.
The public homepage we verified does not provide enough detail to treat the starting monthly figures as a complete checkout quote for every patient or cadence. Before paying, confirm the total amount charged today, renewal timing, whether the selected cadence is prepaid, and the cancellation and refund terms that apply to the order.
Trimi pricing in 2026
Trimi publishes a more detailed pricing ladder.
Compounded semaglutide
| Billing option | Charge | Monthly equivalent |
|---|---|---|
| Monthly | $175 monthly | $175 |
| Three months | $435 every 3 months | $145 |
| Six months | $720 every 6 months | $120 |
| Annual | $1,188 yearly | $99 |
Compounded tirzepatide
| Billing option | Charge | Monthly equivalent |
|---|---|---|
| Monthly | $235 monthly | $235 |
| Three months | $597 every 3 months | $199 |
| Six months | $1,050 every 6 months | $175 |
| Annual | $1,500 yearly | $125 |
The lowest Trimi figures are monthly equivalents, not monthly installments. The annual semaglutide plan is a $1,188 commitment and the annual tirzepatide plan is a $1,500 commitment. Consumers comparing the two programs should compare the amount actually charged at checkout, not only the lowest advertised monthly figure.
Clinician model and prescribing
Nouri says it is a technology platform that connects consumers with independent licensed healthcare providers. Its current FAQ identifies Wasef Health, PC as the clinical care organization and says U.S.-licensed clinicians review the submitted file before deciding whether treatment is appropriate.
Trimi identifies Arora Health as its clinical-infrastructure partner. Its current treatment pages say a provider licensed in the patient’s state reviews the medical history and determines whether treatment is appropriate.
In both cases, completing a questionnaire or paying for a program does not guarantee a prescription. Prescribing decisions belong to the licensed clinician.
Pharmacy transparency
Nouri currently identifies F&F Pharmacies Inc. dba Jungle Jim’s Pharmacy as the pharmacy preparing therapy described on its FAQ and provides the pharmacy’s Fairfield, Ohio address and phone number.
Trimi identifies VialsRx and GreenwichRx as pharmacy partners in its current public materials. The individual prescription and dispensing pharmacy should still be confirmed before payment and fulfillment because pharmacy availability can change.
Named pharmacy information is a useful transparency signal, but it does not make a compounded drug FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or manufacturing quality before marketing in the same way it reviews approved drug products.
State availability
Nouri says it is available in all 50 U.S. states and notes that a video visit is required in some states before a prescription can be written.
Trimi also advertises nationwide availability through its licensed-provider network. Consumers should confirm that the specific clinician, medication pathway, and dispensing pharmacy are available in their state before paying.
Which program has the lower published price?
For semaglutide, Trimi currently publishes the lower headline monthly equivalent at $99, but reaching that figure requires the annual $1,188 prepaid plan. Nouri’s published semaglutide starting figure is $120 per month on its semi-annual cadence.
For tirzepatide, Trimi publishes a $125 monthly equivalent on the annual $1,500 plan, while Nouri says tirzepatide starts at $175 per month.
Those comparisons do not mean Trimi will necessarily cost less for every consumer. A shorter billing commitment, included support, checkout promotions, refund terms, and whether the consumer remains enrolled for the full term can materially change total cost.
Questions to ask before choosing Nouri or Trimi
- What is the exact amount charged today?
- Is the quoted monthly amount an actual monthly charge or a monthly equivalent for a prepaid term?
- What is the renewal date and renewal amount?
- Can the plan be cancelled before the next billing cycle, and when does an order become nonrefundable?
- Which licensed clinician or clinical group will review the case?
- Which pharmacy will dispense the prescription?
- What compounded formulation is being prescribed, and why is a compounded product being considered?
- What support is included after the prescription is issued?
- What happens if the clinician decides treatment is not appropriate?
- What happens if a shipment is delayed, damaged, or arrives with a temperature concern?
Bottom line: Nouri vs Trimi
Nouri and Trimi are both transparent enough to compare, but they emphasize different value propositions. Nouri currently bundles medication access with nutrition and movement planning and publishes named clinical and pharmacy partners. Trimi publishes a more detailed billing ladder and currently offers lower annual-plan monthly equivalents, but the lowest prices require larger prepaid commitments.
A sensible comparison should focus on the total amount charged, commitment length, clinician and pharmacy transparency, included support, cancellation and refund rules, and the compounded-medication model rather than choosing solely on the smallest advertised monthly number.
Medical disclaimer: This page is for consumer education and provider comparison only. It does not provide medical advice, diagnose conditions, recommend a medication, or determine eligibility for prescription treatment. Eligibility and treatment decisions are made by licensed healthcare professionals. Compounded medications are not FDA-approved and may involve additional considerations; discuss risks, benefits, alternatives, and appropriate treatment with a licensed clinician.